Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAASTR3BOLOMIC: Metabolomics for Liver Graft Viability
NCT05361044Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Aug 2022
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoints: Composite endpoint: Number of major liver graft-related adverse events (LGRAE) at 3 years, Identification and Semi Quantification of FMN during normothermic regional perfusion at 3 years and 9 more. Started Aug 2022; status: completed.
Beyond the preview
Go deeper on NCT05361044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361044.